Panbela Therapeutics, Inc. PBLA
0.01 USD 0.00 0.00%
At close · Oct 30
0.0001 52-week range 2.50
- YTD
- +5,450.00%
- 1 year
- +5,450.00%
- Open
- 0.02
- Prev close
- 0.0111
- Mkt cap
- 53.89K
- Vol
- 1.01K
- Avg vol
- 756
- EPS
- -1,915.86
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.02
- High
- 0.02
- Forward P/E
- -0.02
- Beta
- 0.82
- Short ratio
- 0.07
- Inst. own
- 0.60%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 5.07
- 200-d avg
- 30.69
- 1y target
- 410.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for PBLA has not been loaded yet. Try again in a moment.
Altman Z-Score
-60.79 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.0×
P/S 0.0×
P/B -12.1×
P/FCF -2.3×
EV/EBITDA -2.3×
EV/Sales 0.0×
FCF Yield -44.1%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE 536.4%
ROIC -10520.5%
ROA -214.1%
Revenue 0.0%
Operating Income -50.5%
EPS (diluted) -470.4%
Free Cash Flow -58.4%
Current Ratio 0.2×
Quick Ratio 0.2×
Debt / Equity -1.1×
Net Debt / EBITDA -0.1×
Interest Coverage 162×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2023-12-31